551 lines
160 KiB
Text
551 lines
160 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK47338">
|
|
<meta name="ncbi_domain" content="mlprobe">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK47338/?report=reader">
|
|
<meta name="ncbi_pagename" content="Identification of activators for the M2 isoform of human pyruvate kinase - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Identification of activators for the M2 isoform of human pyruvate kinase - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/mlprobe/ml084/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/mlprobe/ml081/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/mlprobe/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="Probe Reports from the NIH Molecular Libraries Program [Internet]">
|
|
<meta name="citation_title" content="Identification of activators for the M2 isoform of human pyruvate kinase">
|
|
<meta name="citation_publisher" content="National Center for Biotechnology Information (US)">
|
|
<meta name="citation_date" content="2010/08/06">
|
|
<meta name="citation_author" content="Douglas Auld">
|
|
<meta name="citation_author" content="Min Shen">
|
|
<meta name="citation_author" content="Amanda P Skoumbourdis">
|
|
<meta name="citation_author" content="Jian-kang Jiang">
|
|
<meta name="citation_author" content="Matthew Boxer">
|
|
<meta name="citation_author" content="Noel Southall">
|
|
<meta name="citation_author" content="James Inglese">
|
|
<meta name="citation_author" content="Craig Thomas">
|
|
<meta name="citation_pmid" content="21433354">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK47338/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Identification of activators for the M2 isoform of human pyruvate kinase">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Center for Biotechnology Information (US)">
|
|
<meta name="DC.Contributor" content="Douglas Auld">
|
|
<meta name="DC.Contributor" content="Min Shen">
|
|
<meta name="DC.Contributor" content="Amanda P Skoumbourdis">
|
|
<meta name="DC.Contributor" content="Jian-kang Jiang">
|
|
<meta name="DC.Contributor" content="Matthew Boxer">
|
|
<meta name="DC.Contributor" content="Noel Southall">
|
|
<meta name="DC.Contributor" content="James Inglese">
|
|
<meta name="DC.Contributor" content="Craig Thomas">
|
|
<meta name="DC.Date" content="2010/08/06">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK47338/">
|
|
<meta name="description" content="The expression of human pyruvate kinase M2 (hPK-M2) in cancer cells appears to be critical for tumor cell growth and proliferation in vivo. Because the PK-M2 isoform is expressed in all cancer cells studied, it represents a target for drug development that could potentially enable tumor cells to return to a normal state of metabolism. If this novel strategy for targeting malignancy were successful, it would be applicable to diverse types of cancer. The probes ML083 (CID-650361) and ML082 (CID-654376) are members of a series of highly specific allosteric activators for the tumor-specific isoform of human pyruvate kinase (M2 isoform). Both probes affect the cooperativity of phosphoenolpyruvate (PEP) binding with little effect on adenosine diphosphate (ADP) binding in a manner similar to FBP.">
|
|
<meta name="og:title" content="Identification of activators for the M2 isoform of human pyruvate kinase">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="The expression of human pyruvate kinase M2 (hPK-M2) in cancer cells appears to be critical for tumor cell growth and proliferation in vivo. Because the PK-M2 isoform is expressed in all cancer cells studied, it represents a target for drug development that could potentially enable tumor cells to return to a normal state of metabolism. If this novel strategy for targeting malignancy were successful, it would be applicable to diverse types of cancer. The probes ML083 (CID-650361) and ML082 (CID-654376) are members of a series of highly specific allosteric activators for the tumor-specific isoform of human pyruvate kinase (M2 isoform). Both probes affect the cooperativity of phosphoenolpyruvate (PEP) binding with little effect on adenosine diphosphate (ADP) binding in a manner similar to FBP.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK47338/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-mlprobe-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/mlprobe/ml083/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK47338/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8D1AE77D669D310000000000260021.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK47338/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/mlprobe/ml084/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Identification of activators for the M2 isoform of human pyruvate kinase</div><div class="j">Probe Reports from the NIH Molecular Libraries Program [Internet]</div></div><div class="tail"><a href="/books/n/mlprobe/ml081/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK47338/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK47338/&text=Identification%20of%20activators%20for%20the%20M2%20isoform%20of%20human%20pyruvate%20kinase"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/mlprobe/?report=reader">Title Information</a><a href="/books/n/mlprobe/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK47338/?report=classic">Switch to classic view</a><a href="/books/NBK47338/pdf/Bookshelf_NBK47338.pdf">PDF (555K)</a><a href="/books/NBK47338/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK47338%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8D1AE77D669D310000000000260021.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK47338_"><span class="title" itemprop="name">Identification of activators for the M2 isoform of human pyruvate kinase</span></h1><p class="contribs">Auld D, Shen M, Skoumbourdis AP, et al.</p><p class="fm-aai"><a href="#_NBK47338_pubdet_">Publication Details</a></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="_abs_rndgid_" itemprop="description"><p> The expression of human pyruvate kinase M2 (hPK-M2) in cancer cells appears to be critical for tumor cell growth and proliferation in vivo. Because the PK-M2 isoform is expressed in all cancer cells studied, it represents a target for drug development that could potentially enable tumor cells to return to a normal state of metabolism. If this novel strategy for targeting malignancy were successful, it would be applicable to diverse types of cancer. The probes ML083 (CID-650361) and ML082 (CID-654376) are members of a series of highly specific allosteric activators for the tumor-specific isoform of human pyruvate kinase (M2 isoform). Both probes affect the cooperativity of phosphoenolpyruvate (PEP) binding with little effect on adenosine diphosphate (ADP) binding in a manner similar to FBP.</p></div><div class="h2"></div><p>
|
|
<b>Assigned Assay Grant #:</b> 1 R03 MH085679-01 </p><p>
|
|
<b>Screening Center Name & PI:</b> NIH Chemical Genomics Center,
|
|
Christopher Austin </p><p>
|
|
<b>Chemistry Center Name & PI:</b> NIH Chemical Genomics Center,
|
|
Christopher Austin </p><p>
|
|
<b>Assay Submitter & Institution:</b> Dr. Matthew George Vander Heiden,
|
|
Harvard </p><p><b>PubChem Primary Bioassay Identifier (AID):</b>
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1631" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1631</a></p><div id="ml083.probestruct"><h2 id="_ml083_probestruct_">Probe Structure and Characteristics</h2><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083tu1"><a href="/books/NBK47338/table/ml083.tu1/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml083tu1" rid-ob="figobml083tu1"><img class="small-thumb" src="/books/NBK47338/table/ml083.tu1/?report=thumb" src-large="/books/NBK47338/table/ml083.tu1/?report=previmg" alt="Probe 1 Structure & Characteristics." /></a><div class="icnblk_cntnt"><h4 id="ml083.tu1"><a href="/books/NBK47338/table/ml083.tu1/?report=objectonly" target="object" rid-ob="figobml083tu1">Table</a></h4><p class="float-caption no_bottom_margin">Probe 1 Structure & Characteristics. </p></div></div><div id="ml083.fu1" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu1.jpg" alt="Image ml083fu1" /></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083tu2"><a href="/books/NBK47338/table/ml083.tu2/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml083tu2" rid-ob="figobml083tu2"><img class="small-thumb" src="/books/NBK47338/table/ml083.tu2/?report=thumb" src-large="/books/NBK47338/table/ml083.tu2/?report=previmg" alt="PubChem Primary Bioassay Identifier (AID): 1631." /></a><div class="icnblk_cntnt"><h4 id="ml083.tu2"><a href="/books/NBK47338/table/ml083.tu2/?report=objectonly" target="object" rid-ob="figobml083tu2">Table</a></h4><p class="float-caption no_bottom_margin">PubChem Primary Bioassay Identifier (AID): 1631. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083tu3"><a href="/books/NBK47338/table/ml083.tu3/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml083tu3" rid-ob="figobml083tu3"><img class="small-thumb" src="/books/NBK47338/table/ml083.tu3/?report=thumb" src-large="/books/NBK47338/table/ml083.tu3/?report=previmg" alt="Probe 2 Structure & Characteristics." /></a><div class="icnblk_cntnt"><h4 id="ml083.tu3"><a href="/books/NBK47338/table/ml083.tu3/?report=objectonly" target="object" rid-ob="figobml083tu3">Table</a></h4><p class="float-caption no_bottom_margin">Probe 2 Structure & Characteristics. </p></div></div><div id="ml083.fu2" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu2.jpg" alt="Image ml083fu2" /></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083tu4"><a href="/books/NBK47338/table/ml083.tu4/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml083tu4" rid-ob="figobml083tu4"><img class="small-thumb" src="/books/NBK47338/table/ml083.tu4/?report=thumb" src-large="/books/NBK47338/table/ml083.tu4/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="ml083.tu4"><a href="/books/NBK47338/table/ml083.tu4/?report=objectonly" target="object" rid-ob="figobml083tu4">Table</a></h4></div></div></div><div id="ml083.rationale"><h2 id="_ml083_rationale_">Recommendations for the scientific use of these probes</h2><div id="ml083.s5"><h3>Specific Aim</h3><p>We aimed to discover and optimize selective modulators of human pyruvate kinase
|
|
M2 (hPK-M2), a splice isoform of pyruvate kinase that is specifically expressed
|
|
in tumor cells. The research has the following specific aims: (1) To identify both activators and
|
|
inhibitors of human M2 PK using a quantitative high-throughput screening
|
|
approach against the MLSMR, containing 300,000 small molecules. (2) To confirm the potency of these
|
|
compounds in a panel of secondary assays, including selectivity assays for the
|
|
human R/L and M1 isoforms of pyruvate kinase which are expressed in most
|
|
differentiated tissues.</p></div><div id="ml083.s6"><h3>Significance</h3><p>Expression of hPK-M2 in cancer cells appears critical for tumor cell growth and
|
|
proliferation <i>in vivo</i>. In addition, the ability of PK-M2 to be
|
|
regulated by both FBP and tyrosine phosphorylated proteins is necessary for
|
|
cancer cell proliferation. Because PK-M2 is the sole pyruvate kinase isoform
|
|
expressed in all cancer cells studied, it represents a target for drug
|
|
development that would enable the inhibition of glucose metabolism in a
|
|
relatively tumor-specific manner. If this novel strategy for targeting
|
|
malignancy were successful, it would be applicable to diverse types of
|
|
cancer.</p></div><div id="ml083.s7"><h3>Rationale</h3><p>PK is a tetrameric enzyme composed of four identical monomers that form a dimer
|
|
of dimers in the final tetrameric structure. In humans, the M2, L, and R
|
|
isozymes are activated by fructose-1,6-bis phosphate (FBP) that binds to a
|
|
flexible loop region at the interface of the two dimers. Activation of PK shifts
|
|
the enzyme to a state showing high affinity for PEP and relieves the cooperative
|
|
kinetics of PEP binding found in the unactivated form (<a class="bibr" href="#ml083.r1" rid="ml083.r1">1</a>). In contrast, the M1 isoform is not regulated by
|
|
FBP and displays only high affinity PEP binding similar to the activated state
|
|
of PK. Importantly, the differentially spliced exons that distinguish PK-M1 from
|
|
PK-M2 are identical in size and encode a 56 amino acid stretch that covers the
|
|
activation loop that allows PK-M2, but not PK-M1, to be allosterically activated
|
|
by FBP (<a class="bibr" href="#ml083.r3" rid="ml083.r3">3</a>).</p><p>Tumor cells undergo a metabolic transformation that is required to supply the
|
|
biochemical precursors necessary for rapid cell growth and proliferation. Otto
|
|
Warburg was first to demonstrate in the 1920s that tumor cells show aberrant
|
|
energy metabolism and noted that cancer cells produce lactate even under aerobic
|
|
conditions (<a class="bibr" href="#ml083.r2" rid="ml083.r2 ml083.r3 ml083.r4">2–4</a>). The property of aerobic glycolysis in tumor cells
|
|
has been termed the “Warburg effect.” This work has
|
|
spawned generations of research on tumor metabolism and the high rate of glucose
|
|
used by tumors is exploited clinically today through the identification of tumor
|
|
cells using 18-fluorodeoxyglucose-PET scanning. This metabolic transformation of
|
|
tumor cells can be achieved by altering the expression of metabolic enzymes.
|
|
Current evidence suggests that expression of PK-M2 in tumor cells has a large
|
|
influence on this process, and that this is due to the unique allosteric
|
|
regulation of PK-M2 (<a class="bibr" href="#ml083.r2" rid="ml083.r2">2</a>,<a class="bibr" href="#ml083.r3" rid="ml083.r3">3</a>). In a recent study it was shown
|
|
that knock-down of PK-M2 and expression of PK-M1 in tumor cell lines was
|
|
sufficient to relieve the Warburg effect and rescue normal cellular respiration
|
|
(<a class="bibr" href="#ml083.r2" rid="ml083.r2">2</a>). In this study, tumor cells
|
|
engineered to express PK-M1 showed a reduced ability to form tumors in nude
|
|
mouse xenografts. As well, in related study, a link between PK-M2 and growth
|
|
factors that produce phosphotyrosine polypeptides in tumor cells was
|
|
demonstrated (<a class="bibr" href="#ml083.r3" rid="ml083.r3">3</a>). In that study it
|
|
was found that various phosphotyrosine peptides can bind to PK-M2 near the
|
|
activation loop, which results in the removal of FBP from the enzyme which
|
|
effectively down-regulates PK-M2 activity. This cascade leads to a building up
|
|
of glycolytic intermediates that can be diverted towards nucleotide and lipid
|
|
biosynthesis required for cell growth and proliferation.<sup>3</sup> These
|
|
studies suggest that growth factor signaling decreases PK-M2 activity, and that
|
|
this decrease in activity contributes to both the Warburg effect (<a class="bibr" href="#ml083.r4" rid="ml083.r4">4</a>) and the ability of tumor cells to
|
|
proliferate. Taken together, these studies imply a therapeutic strategy where
|
|
activation of PK-M2 should return normal cellular metabolism in a manner similar
|
|
to the experiments described above where tumor cells were rescued by the
|
|
expression of the constitutively active PK-M1 isozyme.</p><div id="ml083.fu3" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu3.jpg" alt="A) Shown is normal respiration occurring in non-cancerous cell-types" /></div><div class="caption"><p><b>A)</b> Shown is normal respiration occurring in non-cancerous
|
|
cell-types. PK-M1 is constitutively active and acts primarily to drive
|
|
ATP formation. <b>B)</b> Shown is altered metabolism that occurs
|
|
in cancer cells. In this case, the activity of the PK-M2 isoform is
|
|
activated by phosphorylated sugars (e.g. FBP) and inhibited by
|
|
tyrosine-phosphorylated proteins derived from growth factor signaling.
|
|
The decrease in activity of PK-M2 in response to growth signals is
|
|
predicted to build-up intermediates of glycolysis and feed proliferation
|
|
of the cancer cells.</p></div></div></div></div><div id="ml083.s8"><h2 id="_ml083_s8_">Assay Implementation and Screening</h2><div id="ml083.s9"><h3>PubChem Bioassay Name</h3><p><i>Dmel</i> lipid storage</p></div><div id="ml083.s10"><h3>List of PubChem bioassay identifiers generated for this screening project
|
|
(AIDS)</h3><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083tu5"><a href="/books/NBK47338/table/ml083.tu5/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml083tu5" rid-ob="figobml083tu5"><img class="small-thumb" src="/books/NBK47338/table/ml083.tu5/?report=thumb" src-large="/books/NBK47338/table/ml083.tu5/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="ml083.tu5"><a href="/books/NBK47338/table/ml083.tu5/?report=objectonly" target="object" rid-ob="figobml083tu5">Table</a></h4></div></div></div><div id="ml083.s11"><h3>Primary Assay Description as defined in PubChem</h3><div id="ml083.s12"><h4>Overview</h4><p>To develop a robust assay for PK we took advantage of a well-utilized
|
|
luminescent assay detection system for protein kinases (<a class="bibr" href="#ml083.r5" rid="ml083.r5">5</a>,<a class="bibr" href="#ml083.r6" rid="ml083.r6">6</a>).
|
|
Typically, these assays use the ATP-dependent reaction catalyzed by firefly
|
|
luciferase to measure ATP depletion by protein kinases. In the present assay
|
|
we applied this assay to measure ATP production catalyzed by PK. This
|
|
provides for a robust increase in luminescent signal upon ATP product
|
|
formation (<a class="figpopup" href="/books/NBK47338/figure/ml083.f1/?report=objectonly" target="object" rid-figpopup="figml083f1" rid-ob="figobml083f1">Figure 2</a>) (<a class="bibr" href="#ml083.r7" rid="ml083.r7">7</a>). The primary high-throughput
|
|
screen was performed in 1536-well microtiter plates using 4 uL/well assay
|
|
volume with final concentrations of 0.1 nM human PK M2, 0.5 mM PEP, 0.1 mM
|
|
ADP in assay buffer that contained 50 mM Imidazole pH 7.2, 50 mM KCl, 7 mM
|
|
MgCl2, 0.01% Tween, 0.05% BSA. For compound transfer
|
|
we used a pintool equipped with a 1536 pins that each transferred 23 nL of a
|
|
DMSO solution containing compound. The enzymatic reaction was allowed to
|
|
proceed for 60 minutes and then ATP was detected using a bioluminescent
|
|
detection reagent containing D-luciferin and firefly luciferase (Kinase-Glo,
|
|
Promega) (<a class="bibr" href="#ml083.r8" rid="ml083.r8">8</a>). The detection
|
|
reagent also effectively stopped the PK reaction. Luminescence was then
|
|
measured on the Perkin Elmer Viewlux using an exposure of 2 secs (with 2X
|
|
binning). The final concentration of DMSO in the enzyme assay is
|
|
0.5% and was found not to affect the assay signal.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f1" co-legend-rid="figlgndml083f1"><a href="/books/NBK47338/figure/ml083.f1/?report=objectonly" target="object" title="Figure 2" class="img_link icnblk_img figpopup" rid-figpopup="figml083f1" rid-ob="figobml083f1"><img class="small-thumb" src="/books/NBK47338/bin/ml083f1.gif" src-large="/books/NBK47338/bin/ml083f1.jpg" alt="Figure 2. Pyruvate kinase-luciferase coupled assay." /></a><div class="icnblk_cntnt" id="figlgndml083f1"><h4 id="ml083.f1"><a href="/books/NBK47338/figure/ml083.f1/?report=objectonly" target="object" rid-ob="figobml083f1">Figure 2</a></h4><p class="float-caption no_bottom_margin">Pyruvate kinase-luciferase coupled assay. </p></div></div><p>All compounds were screened using a qHTS approach, where compounds are
|
|
assayed using at least seven concentrations to generate
|
|
concentration-response curves for every compounds (<a class="bibr" href="#ml083.r7" rid="ml083.r7">7</a>). The methodology for creating a
|
|
concentration-titration series between successive copies of library plates
|
|
for the purpose of large-scale titration-based screening has been described
|
|
(<a class="bibr" href="#ml083.r9" rid="ml083.r9">9</a>). Briefly, qHTS uses an
|
|
inter-plate dilution method where the first plate contains the highest
|
|
concentration of a set of compounds in DMSO, while subsequent plates contain
|
|
the same compounds in the same well locations, but at successive lower
|
|
concentrations. Using the protocol outlined above we calculated a plate
|
|
throughput of 18 plates/hr or approximately 7 samples/sec on the Kalypsys
|
|
robotic system which means that a 7 point CRC was obtained every second on
|
|
the robotic system.</p></div></div><div id="ml083.s13"><h3>Summary of the Primary Screen</h3><div id="ml083.s14"><h4>Assay protocol</h4><p>The optimized 1536-well protocol is given in <a class="figpopup" href="/books/NBK47338/table/ml083.t1/?report=objectonly" target="object" rid-figpopup="figml083t1" rid-ob="figobml083t1">Table 1</a>.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083t1"><a href="/books/NBK47338/table/ml083.t1/?report=objectonly" target="object" title="Table 1" class="img_link icnblk_img figpopup" rid-figpopup="figml083t1" rid-ob="figobml083t1"><img class="small-thumb" src="/books/NBK47338/table/ml083.t1/?report=thumb" src-large="/books/NBK47338/table/ml083.t1/?report=previmg" alt="Table 1. Final 1536-well assay protocol." /></a><div class="icnblk_cntnt"><h4 id="ml083.t1"><a href="/books/NBK47338/table/ml083.t1/?report=objectonly" target="object" rid-ob="figobml083t1">Table 1</a></h4><p class="float-caption no_bottom_margin">Final 1536-well assay protocol. </p></div></div><div id="ml083.f2" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47338/bin/ml083f2.jpg" alt="Figure 2. qHTS Performance Summary." /></div><h3><span class="label">Figure 2</span><span class="title">qHTS Performance Summary</span></h3></div><div id="ml083.s15"><h5>Identification of hPK M2 Activators</h5><p>Following the qHTS the CRC data was subjected to a classification scheme
|
|
to rank the quality of the CRCs as described by Inglese and coworkers
|
|
(<a class="bibr" href="#ml083.r7" rid="ml083.r7">7</a>) (see <a class="figpopup" href="/books/NBK47338/figure/ml083.f3/?report=objectonly" target="object" rid-figpopup="figml083f3" rid-ob="figobml083f3">scheme 1</a>). Briefly, CRCs are
|
|
placed into four classes. Class 1 contains complete CRCs showing both
|
|
upper and lower asymptotes and r<sup>2</sup> values > 0.9. Class
|
|
2 contains incomplete CRCs lacking the lower asymptote and shows
|
|
r<sup>2</sup> values greater than 0.9. Class 3 curves are of the
|
|
lowest confidence because they are defined by a single concentration
|
|
point where the minimal acceptable activity is set at 3 SD of the mean
|
|
activity calculated from the lowest tested concentration. Finally, class
|
|
4 contains compounds that do not show any CRCs and are therefore
|
|
classified as inactive.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f3" co-legend-rid="figlgndml083f3"><a href="/books/NBK47338/figure/ml083.f3/?report=objectonly" target="object" title="Scheme 1" class="img_link icnblk_img figpopup" rid-figpopup="figml083f3" rid-ob="figobml083f3"><img class="small-thumb" src="/books/NBK47338/bin/ml083f3.gif" src-large="/books/NBK47338/bin/ml083f3.jpg" alt="Scheme 1. Example qHTS data and classification scheme for assignment of resulting curve-fit data into classes." /></a><div class="icnblk_cntnt" id="figlgndml083f3"><h4 id="ml083.f3"><a href="/books/NBK47338/figure/ml083.f3/?report=objectonly" target="object" rid-ob="figobml083f3">Scheme 1</a></h4><p class="float-caption no_bottom_margin">Example qHTS data and classification scheme for assignment of
|
|
resulting curve-fit data into classes. <i>Top</i>, qHTS curve-fit data from AID-361 binned into
|
|
curve classifications 1–4 based classification
|
|
criteria. <i>Below</i>, Examples of curves fitting the
|
|
following <a href="/books/NBK47338/figure/ml083.f3/?report=objectonly" target="object" rid-ob="figobml083f3">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f4" co-legend-rid="figlgndml083f4"><a href="/books/NBK47338/figure/ml083.f4/?report=objectonly" target="object" title="Figure 3" class="img_link icnblk_img figpopup" rid-figpopup="figml083f4" rid-ob="figobml083f4"><img class="small-thumb" src="/books/NBK47338/bin/ml083f4.gif" src-large="/books/NBK47338/bin/ml083f4.jpg" alt="Figure 3. Summary of activity from the qHTS." /></a><div class="icnblk_cntnt" id="figlgndml083f4"><h4 id="ml083.f4"><a href="/books/NBK47338/figure/ml083.f4/?report=objectonly" target="object" rid-ob="figobml083f4">Figure 3</a></h4><p class="float-caption no_bottom_margin">Summary of activity from the qHTS. The table summarizes the number actives associated with CRC
|
|
classes described in Scheme
|
|
1(highlighted in red are the percentages for the high
|
|
quality activating CRCs. The flow chart below summarizes the how
|
|
this information <a href="/books/NBK47338/figure/ml083.f4/?report=objectonly" target="object" rid-ob="figobml083f4">(more...)</a></p></div></div></div></div></div><div id="ml083.s16"><h3>Probe Characterization</h3><div id="ml083.fu4" class="figure bk_fig"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu4.jpg" alt="Mode of action." /></div><h3><span class="title">Mode of action</span></h3><div class="caption"><p>Both CID-650361 (<b>A</b>) and CID-654376 (<b>B</b>) affect
|
|
the cooperativity of PEP binding with little affect on ADP binding in a
|
|
manner similar to FBP but with lower efficacy. Kinetics of substrate
|
|
binding in the presence (open circles) or absence (filled squares) of
|
|
activator (10 μM was used). Vo, initial rate in pmol/min as
|
|
determined in the PK-LDH coupled assay</p></div></div><div id="ml083.s18"><h4>Synthesis of analogs CID-650361</h4><div id="ml083.s19"><h5>General procedure for the synthesis of analogues</h5><p>The bis-sulfonamide was elaborated upon via the synthetic strategy
|
|
outline in <a class="figpopup" href="/books/NBK47338/figure/ml083.f5/?report=objectonly" target="object" rid-figpopup="figml083f5" rid-ob="figobml083f5">Scheme 1</a>. A Boc
|
|
protected piperizine (alternate ring systems were additionally explored;
|
|
for instance, 1,4-diazepane,
|
|
2,6-diazabicyclo[3.2.1]octane,
|
|
2,5-diazabicyclo[2.2.1]heptane,
|
|
2-methylpiperazine and piperazin-2-one) was treated with selected
|
|
sulfonyl chlorides in basic methylene chloride. Boc removal was
|
|
accomplished by treatment with trifluoroacetic acid, and a subsequent
|
|
treatment with selected sulfonyl chlorides in basic methylene chloride
|
|
provided numerous analogues.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f5" co-legend-rid="figlgndml083f5"><a href="/books/NBK47338/figure/ml083.f5/?report=objectonly" target="object" title="Scheme 1" class="img_link icnblk_img figpopup" rid-figpopup="figml083f5" rid-ob="figobml083f5"><img class="small-thumb" src="/books/NBK47338/bin/ml083f5.gif" src-large="/books/NBK47338/bin/ml083f5.jpg" alt="Scheme 1" /></a><div class="icnblk_cntnt" id="figlgndml083f5"><h4 id="ml083.f5"><a href="/books/NBK47338/figure/ml083.f5/?report=objectonly" target="object" rid-ob="figobml083f5">Scheme 1</a></h4></div></div><p>Additionally, numerous derivatives were synthesized that incorporated
|
|
selected amide functions in place of sulfonamides. The synthesis of
|
|
these analogues followed similar methods and is outlined in <a class="figpopup" href="/books/NBK47338/figure/ml083.f6/?report=objectonly" target="object" rid-figpopup="figml083f6" rid-ob="figobml083f6">Scheme 2</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f6" co-legend-rid="figlgndml083f6"><a href="/books/NBK47338/figure/ml083.f6/?report=objectonly" target="object" title="Scheme 2" class="img_link icnblk_img figpopup" rid-figpopup="figml083f6" rid-ob="figobml083f6"><img class="small-thumb" src="/books/NBK47338/bin/ml083f6.gif" src-large="/books/NBK47338/bin/ml083f6.jpg" alt="Scheme 2" /></a><div class="icnblk_cntnt" id="figlgndml083f6"><h4 id="ml083.f6"><a href="/books/NBK47338/figure/ml083.f6/?report=objectonly" target="object" rid-ob="figobml083f6">Scheme 2</a></h4></div></div><p>It was also of interest to explore selected sulfone moieties in place of
|
|
the sulfonamides. To achieve these derivatives, we first displaced the
|
|
halogen on 4-bromopiperidine (alternate ring systems were additionally
|
|
explored; for instance 4-bromoazepane) via attach by selected aromatic
|
|
thiols in basic <i>N,N</i>-dimethylformamide (<a class="figpopup" href="/books/NBK47338/figure/ml083.f7/?report=objectonly" target="object" rid-figpopup="figml083f7" rid-ob="figobml083f7">Scheme 3</a>). Oxidation with
|
|
meta-chloroperbenzoic acid provided the sulfones and the remainder of
|
|
the synthesis followed the strategy outline in <a class="figpopup" href="/books/NBK47338/figure/ml083.f5/?report=objectonly" target="object" rid-figpopup="figml083f5" rid-ob="figobml083f5">Scheme 1</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f7" co-legend-rid="figlgndml083f7"><a href="/books/NBK47338/figure/ml083.f7/?report=objectonly" target="object" title="Scheme 3" class="img_link icnblk_img figpopup" rid-figpopup="figml083f7" rid-ob="figobml083f7"><img class="small-thumb" src="/books/NBK47338/bin/ml083f7.gif" src-large="/books/NBK47338/bin/ml083f7.jpg" alt="Scheme 3" /></a><div class="icnblk_cntnt" id="figlgndml083f7"><h4 id="ml083.f7"><a href="/books/NBK47338/figure/ml083.f7/?report=objectonly" target="object" rid-ob="figobml083f7">Scheme 3</a></h4></div></div><p>Additional efforts surrounded the incorporation of selected functionality
|
|
directly on the piperizine ring system (alternate ring systems were
|
|
additionally explored; for instance, 1,4-diazepane, 2-methylpiperazine
|
|
and piperazin-2-one). In these efforts, the utility of appropriately
|
|
substituted piperazin-2-ones were treated with lithium
|
|
hexamethyldisilazide followed by Selectfluor® to accomplish
|
|
the fluorination of the ring system. These analogues were explored
|
|
further by direct reduction of the carbonyl with borane (<a class="figpopup" href="/books/NBK47338/figure/ml083.f8/?report=objectonly" target="object" rid-figpopup="figml083f8" rid-ob="figobml083f8">Scheme 4</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f8" co-legend-rid="figlgndml083f8"><a href="/books/NBK47338/figure/ml083.f8/?report=objectonly" target="object" title="Scheme 4" class="img_link icnblk_img figpopup" rid-figpopup="figml083f8" rid-ob="figobml083f8"><img class="small-thumb" src="/books/NBK47338/bin/ml083f8.gif" src-large="/books/NBK47338/bin/ml083f8.jpg" alt="Scheme 4" /></a><div class="icnblk_cntnt" id="figlgndml083f8"><h4 id="ml083.f8"><a href="/books/NBK47338/figure/ml083.f8/?report=objectonly" target="object" rid-ob="figobml083f8">Scheme 4</a></h4></div></div></div><div id="ml083.s20"><h5>SAR of CID650361 analogs</h5><p>The SAR of the bis-sulfonamide chemotype was explored on multiple
|
|
fronts. The central ring system was found to be necessary as was the
|
|
presence of the sulfonamides (amides were not active). Further, both
|
|
aryl derivatives were altered to gain an appreciation of their
|
|
effect on activity. The lone phenyl ring was explored with standard
|
|
substitutions (F, Me, OMe, Cl, CF3) at all positions (ortho, meta,
|
|
para) and several di-substitutions were explored (see table).
|
|
Additionally, the
|
|
2,3-dihydrobenzo[b][1,4]dioxine
|
|
heterocycle was altered. Related heterocycles and substituted phenyl
|
|
rings were explored. Symmetric versions of this chemotype were also
|
|
explored and found to be active.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083tu6"><a href="/books/NBK47338/table/ml083.tu6/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml083tu6" rid-ob="figobml083tu6"><img class="small-thumb" src="/books/NBK47338/table/ml083.tu6/?report=thumb" src-large="/books/NBK47338/table/ml083.tu6/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="ml083.tu6"><a href="/books/NBK47338/table/ml083.tu6/?report=objectonly" target="object" rid-ob="figobml083tu6">Table</a></h4></div></div></div></div><div id="ml083.s21"><h4>Synthesis of analogs CID-654376</h4><p>The 2-(benzyl)pyridazin-3(2H)-one based heterocycle was expanded via the
|
|
synthetic strategy outline in <a class="figpopup" href="/books/NBK47338/figure/ml083.f9/?report=objectonly" target="object" rid-figpopup="figml083f9" rid-ob="figobml083f9">Scheme
|
|
5</a>. Mixing a 5-substituted thiophene-2-carbaldehyde (substitutions
|
|
included alkyl groups and halogens) and ethyl 2-azidoacetate in basic
|
|
ethanol provided the (Z)-ethyl
|
|
2-azido-3-(5-substituted-thiophen-2-yl)acrylates, which can be directly
|
|
cyclized to ethyl
|
|
2-substituted-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
by refluxing in O-xylene. Treatment of this heterocycle with piperidine and
|
|
formaldehyde in glacial acetic acid produced the ethyl
|
|
2-methyl-6-(piperidin-1-ylmethyl)-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
that can be methylated (the quarternary amine is preferred) and converted to
|
|
the aldehyde. Treatment of the ethyl
|
|
6-formyl-2-substituted-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
with methyl iodide in basic conditions (K<sub>2</sub>CO<sub>3</sub>, DMF)
|
|
directly methylates the pyrole nitrogen [NOTE: it is essential
|
|
to alkylate the pyrole nitrogen at this synthetic step to avoid competition
|
|
with the pyridazin-3(2H)-one nitrogens]. Treatment with
|
|
hydrazine forms the pyridazin-3(2H)-one ring system and alkylation with
|
|
selected benzyl bromides provides the final structures.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml083f9" co-legend-rid="figlgndml083f9"><a href="/books/NBK47338/figure/ml083.f9/?report=objectonly" target="object" title="Scheme 5" class="img_link icnblk_img figpopup" rid-figpopup="figml083f9" rid-ob="figobml083f9"><img class="small-thumb" src="/books/NBK47338/bin/ml083f9.gif" src-large="/books/NBK47338/bin/ml083f9.jpg" alt="Scheme 5" /></a><div class="icnblk_cntnt" id="figlgndml083f9"><h4 id="ml083.f9"><a href="/books/NBK47338/figure/ml083.f9/?report=objectonly" target="object" rid-ob="figobml083f9">Scheme 5</a></h4></div></div><div id="ml083.s22"><h5>General procedure for the synthesis of analogues</h5><div id="ml083.fu5" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu6.jpg" alt="Image ml083fu6" /></div></div><p>Synthesis of (Z)-ethyl 2-azido-3-(5-substituted-thiophen-2-yl)acrylates.
|
|
A solution of sodium (2.76 g, 120 mmol) in absolute EtOH (120 ml) was
|
|
cooled in an ice-bath and a mixture of 5-substituted-2-formylthiophene
|
|
(5.73 g, 30 mmol) and ethyl azidoacetate (15.49 g, 120 mmol) was added
|
|
dropwise during 30 min period. The bath was removed and the reaction
|
|
mixture was stirred at room temperature for another 30 min. A cold
|
|
solution of saturated aqueous NH<sub>4</sub>Cl solution (100 ml) was
|
|
added and the resulting solution was extracted with diethyl ether (3x100
|
|
ml) and the combined organic layers were washed with brine (200 ml),
|
|
dried over Na<sub>2</sub>SO<sub>4</sub>. After removing diethyl ether
|
|
under reduced pressure, the crude product was purified by column
|
|
chromatography (EtOAc/Hexane 1/50) to give substituted acrylates as
|
|
light yellow solids</p><div id="ml083.fu6" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu7.jpg" alt="Image ml083fu7" /></div></div><p>Synthesis of ethyl
|
|
2-substituted-4H-thieno[3,2-b]pyrrole-5-carboxylate.</p><p>A solution of substituted acrylates (3.81 g, 12.6 mmol) in
|
|
<i>o</i>-xylene was refluxed for 20 min. After removing
|
|
the <i>o</i>-xylene, the crude product was purified by column
|
|
chromatography (EtOAc/Hexane 1/10) to give substituted
|
|
thieno[3,2-<i>b</i>]pyrroles as
|
|
white solids.</p><div id="ml083.fu7" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu8.jpg" alt="Image ml083fu8" /></div></div><p>Synthesis of ethyl
|
|
2-substituted-6-(piperidin-1-ylmethyl)-4H-thieno[3,2-b]pyrrole-5-carboxylate.</p><p>Piperidine (1.02 ml, 10.2 mmol), 37% aqueous formaldehyde
|
|
(0.80 ml, 10.2 mmol) and substituted
|
|
thieno[3,2-<i>b</i>]pyrrole (2.80
|
|
g, 10.2 mmol) were added to glacial acetic acid (3 ml) with ice-bath
|
|
cooling. The mixture was heated to 95 °C for 30 min and
|
|
allowed to react at room temperature overnight. After adding
|
|
H<sub>2</sub>O (10 ml), the mixture was adjusted to pH 8 by slow
|
|
addition of saturated aqueous K<sub>2</sub>CO<sub>3</sub> solution and
|
|
resulting solution was extracted with diethyl ether (3x15 ml). The
|
|
combined organic layers were washed with brine, dried over
|
|
Na<sub>2</sub>SO<sub>4</sub>. After removing the organic solvent
|
|
under reduced pressure, the residue was purified by column
|
|
chromatography (EtOAc/Hexane 1/2) to give the desired substituted
|
|
Mannich bases as white solids</p><div id="ml083.fu8" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu9.jpg" alt="Image ml083fu9" /></div></div><p>Synthesis of
|
|
1-((5-(ethoxycarbonyl)-2-substituted-4H-thieno[3,2-b]pyrrol-6-yl)methyl)-1-methylpiperidinium
|
|
iodides.</p><p>A solution of substituted Mannich bases (2.70 g, 7.30 mmol) in diethyl
|
|
ether (60 ml) was added dropwise to iodomethane (15 ml) with stirring in
|
|
30 min. The resulting mixture was refluxed for 2 hr. After cooling to
|
|
room temperature, the mixture was refrigerated at −20
|
|
°C overnight. The solid was filtered and washed with diethyl
|
|
ether to give the desired iodo salts as light yellow solids.</p><div id="ml083.fu9" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu10.jpg" alt="Image ml083fu10" /></div></div><p>Synthesis of ethyl
|
|
6-formyl-2-substituted-4H-thieno[3,2-b]pyrrole-5-carboxylates.</p><p>To a flask containing glacial acetic acid (5 ml) was added
|
|
1-((5-(ethoxycarbonyl)-2-substituted-4H-thieno[3,2-b]pyrrol-6-yl)methyl)-1-methylpiperidinium
|
|
iodides (2.30 g, 4.48 mmol) and the mixture was heated to 115
|
|
°C (oil bath), and hexamethylenetetramine (4.40 g, 31.4
|
|
mmol) was added as one portion and the temperature was kept at 115
|
|
°C for 20 min. After cooling to room temperature,
|
|
H<sub>2</sub>O (20 ml) was added and the resulting mixture was
|
|
extracted with EtOAc (3x25 ml) and the combined organic layers were
|
|
washed with saturated aqueous NaHCO<sub>3</sub> solution and brine.
|
|
After drying over Na<sub>2</sub>SO<sub>4</sub>, the organic solvent was
|
|
removed under reduced pressure and the residue was purified by column
|
|
chromatography (EtOAc/Hexane 1/6) to give the desired ethyl
|
|
6-formyl-2-substituted-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
(302 mg, 40%) as white solids.</p><div id="ml083.fu10" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu11.jpg" alt="Image ml083fu11" /></div></div><p>Synthesis of ethyl
|
|
6-formyl-2,4-disubstituted-4H-thieno[3,2-b]pyrrole-5-carboxylates.</p><p>To a solution of ethyl
|
|
6-formyl-2-substituted-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
(515 mg, 1.70 mmol) in DMF (5 ml) was added potassium carbonate (707 mg,
|
|
5.12 mmol) and iodomethane (0.27 ml, 3.40 mmol), and the resulting
|
|
mixture was stirred at room temperature for 2 hr. To the mixture was
|
|
added H<sub>2</sub>O (30 ml) and EtOAc (50 ml) and the organic layer was
|
|
separated and washed with brine, dried over
|
|
Na<sub>2</sub>SO<sub>4</sub>. After removing the organic solvent under
|
|
reduced pressure, the residue was purified by column chromatography
|
|
(EtOAc/Hexane 1/8) to give the desired <i>N</i>-methylated
|
|
ethyl
|
|
6-formyl-2,4-disubstituted-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
(440 mg, 82%) as a white solid.</p><div id="ml083.fu11" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu12.jpg" alt="Image ml083fu12" /></div></div><p>Synthesis of substituted pyridazin-3(2H)-ones.</p><p>The
|
|
6-formyl-2,4-disubstituted-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
(420 mg, 1.33 mmol) was dissolved in warm 2-ethoxyethanol (26 ml). To a
|
|
refluxed solution of hydrazine monohydrate (1 ml, 31.9 mmol) and
|
|
2-ethoxyethanol (5 ml) under nitrogen was added prepared
|
|
<i>N</i>-methylated ethyl
|
|
6-formyl-2,4-disubstituted-4H-thieno[3,2-b]pyrrole-5-carboxylates
|
|
solution dropwise over a 2 hr period, and the solution continued to
|
|
reflux for additional 1 hr. After cooling to room temperature, about
|
|
half of the 2-ethoxyethanol was removed under reduced pressure and the
|
|
remaining solution was refrigerated at −20 °C
|
|
overnight. The precipitate was filtered and washed with 2-ethoxyethanol
|
|
to give desired substituted pyridazin-3(2H)-ones (354 mg,
|
|
94%) as white solids.</p><div id="ml083.fu12" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu13.jpg" alt="Image ml083fu13" /></div></div><p>Synthesis of substituted 2-benzylpyridazin-3(2H)-ones.</p><p>To a solution of substituted pyridazin-3(2H)-ones (354 mg, 1.25 mmol) in
|
|
DMF (5 ml) was added potassium carbonate (1.02 g, 7.35 mmol) and
|
|
2-fluorobenzyl bromide (0.94, 4.98), and the resulting mixture was
|
|
heated at 60 °C for 2 hr. After cooling to room temperature,
|
|
to the mixture H<sub>2</sub>O (20 ml) and EtOAc (50 ml) was added and
|
|
the organic layer was separated and washed with brine, dried over
|
|
Na<sub>2</sub>SO<sub>4</sub>. After removing the solvent under
|
|
reduced pressure, the residue was purified by column chromatography
|
|
(EtOAc/Hexane 1/4) to give substituted 2-benzylpyridazin-3(2H)-ones (371
|
|
mg, 76%) as white solids</p><div id="ml083.fu13" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu14.jpg" alt="Image ml083fu14" /></div></div><p><b>2,4-dimethyl-4H-thieno[3,2-b]pyrrole-2-(2-fluorobenzyl)pyridazin-3(2H)-one.</b>
|
|
<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.64 (d, 3H,
|
|
<i>J</i>=1.2 Hz), 4.27 (s, 3H), 5.53 (s, 2H),
|
|
6.92 (q, 1H, <i>J</i>=1.2 Hz),
|
|
7.02–7.09 (m, 2H), 7.19–7.26 (m, 2H), 8.20 (s,
|
|
1H). HRMS; Calculated for
|
|
C<sub>17</sub>H<sub>15</sub>FN<sub>3</sub>OS+
|
|
(M+H): 328.0920, found: 328.0925.</p></div><div id="ml083.s23"><h5>SAR of CID-654376 analogs</h5><p>The SAR of the substituted 2-benzylpyridazin-3(2H)-one chemotype was
|
|
explored on multiple fronts. The central 6:5:5 ring system was found to
|
|
be necessary as was the presence of the alkyl group of off the central
|
|
pyrole ring (methyl>ethyl>isoproply). Further, alkyl
|
|
groups at the 2 position of the thiophene ring were limited by size
|
|
(again, methyl>ethyl>isoproply). The lone phenyl ring was
|
|
explored with standard substitutions (F, Me, OMe, Cl, CF3) at all
|
|
positions (ortho, meta, para) and several di-substitutions were explored
|
|
(see table). Additionally, the 2-position of the thiophene ring was
|
|
explored in terms of heteroatomic substitutions (OMe, SMe, S(O)Me,
|
|
S(O<sub>2</sub>)Me, NO<sub>2</sub>) with varying results.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml083tu7"><a href="/books/NBK47338/table/ml083.tu7/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figml083tu7" rid-ob="figobml083tu7"><img class="small-thumb" src="/books/NBK47338/table/ml083.tu7/?report=thumb" src-large="/books/NBK47338/table/ml083.tu7/?report=previmg" alt="SAR of CID-654376 analogs." /></a><div class="icnblk_cntnt"><h4 id="ml083.tu7"><a href="/books/NBK47338/table/ml083.tu7/?report=objectonly" target="object" rid-ob="figobml083tu7">Table</a></h4><p class="float-caption no_bottom_margin">SAR of CID-654376 analogs. </p></div></div><p>These compounds have been provided to the MLSMR: </p><p><b>MLS-00030964 (CID-650361)</b></p><p>
|
|
<i>Canonical SMILES</i>:
|
|
COC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)S(=O)(=O)C3=CC4=C(C=C3)OCCO4</p><p>
|
|
<i>InChI</i>: InChI
|
|
=1S/C19H22N2O7S2/c1-26-15-2-4-16(5-3-15)29(22,
|
|
23)20-8-10-21(11-9-20)30(24,25)17-6-7-18-19(14–17)28-13-12-27-18/h2-7,
|
|
14H,8-13H2,1H3 </p><p><b>MLS-000076148 (CID-654376)</b></p><p>
|
|
<i>Canonical SMILES:</i>
|
|
CC1=CC2=C(S1)C3=C(N2C)C(=O)N(N=C3)CC4=CC=CC=C4F </p><p>
|
|
<i>InChI</i>:
|
|
InChI=1S/C17H14FN3OS/c1-10-7-14-16(23-10)12-8-19-21(17(22)15(12)20(14)2)
|
|
9-11-5-3-4-6-13(11)18/h3-8H,9H2,1-2H3 </p></div></div><div id="ml083.s25"><h4>Description of secondary assays used in probe characterization</h4><div id="ml083.s26"><h5>PK-LDH coupled</h5><p>A second assay was used to evaluate compounds. This assay couples the
|
|
formation of pyruvate from PK using lactate dehydrogenase (LDH) and
|
|
NADH. The depletion of NADH is followed in a fluorescent-based kinetic
|
|
assay that follows the formation of pyruvate to lactate, as catalyzed
|
|
LDH (described in ref [10]). This format can be
|
|
used to determine kinetic parameters and mechanism of action for
|
|
activators/inhibitors. This kinetic assay used 1 nM human PK-M2, and
|
|
initial rates are determined by measuring the fluorescence signal every
|
|
30 secs for 10 minutes. The same assay was used for isoform
|
|
selectivity.</p></div><div id="ml083.s27"><h5>Compound preparation</h5><p>Compound is prepared in DMSO at 10 mM stock concentration. Assays
|
|
described above have 0.6% DMSO final concentration in
|
|
buffer.</p></div></div></div></div><div id="ml083.s28"><h2 id="_ml083_s28_">Known probe properties</h2><p>Summary of probe properties (solubility, absorbance/fluorescence, reactivity,
|
|
toxicity, etc.) and recommendations for the scientific use of probe as research
|
|
tool:</p><div id="ml083.s29"><h3>1. Probe</h3><div id="ml083.s30"><h4>a. Chemical name</h4><p>
|
|
1-(2,3-dihydrobenzo[b][1,4]dioxin-6-ylsulfonyl)-4-(4-methoxyphenylsulfonyl)piperazine
|
|
[<a href="/pcsubstance/?term=ML083[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML083</a>]
|
|
</p></div><div id="ml083.s31"><h4>b. Probe chemical structure</h4><div id="ml083.fu14" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu16.jpg" alt="Image ml083fu16" /></div></div></div><div id="ml083.s32"><h4>c. Structural Verification Information of probe SID</h4><p><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>6) δ: 2.94 (s,
|
|
8H), 3.86 (s, 3H), 4.23–4.45 (m, 4H), 7.01–7.08 (m,
|
|
1H), 7.08–7.19 (m, 4H), 7.57–7.67 (m, 2H). HRMS;
|
|
Calculated for
|
|
C<sub>19</sub>H<sub>22</sub>N<sub>2</sub>O<sub>7</sub>S<sub>2</sub>
|
|
(M+): 454.0868, found: 454.0865.</p></div><div id="ml083.s33"><h4>d. PubChem CID (corresponding to the SID)</h4><p>CID-650361</p></div><div id="ml083.s34"><h4>e. Availability from a vendor</h4><p>Aliquots of MLS-00030964-01 (CID-650361) is available from the NCGC upon
|
|
request.</p></div><div id="ml083.s35"><h4>f. Mode of action for biological activity of probe</h4><p>The probe is a member of a series of highly specific allosteric activators
|
|
for the tumor-specific isoform of human pyruvate kinase (M2 isoform). The
|
|
activation occurs in a manner that is kinetically similar to the natural
|
|
activator (FBP) by decreasing the Km for PEP and reducing the cooperative
|
|
binding of PEP. Preliminary X-ray data obtained for co-crystals of
|
|
NCGC00030335 bound to human PK M2 (see PDB:3GQY) suggests this occurs by
|
|
binding at interface that spans the dimer-dimer interaction region of the
|
|
tetramer, which we infer stabilizes the high affinity R-state of the
|
|
tetramer.</p></div><div id="ml083.s36"><h4>g. Detailed synthetic pathway for making probe</h4><p>See schemes above.</p></div><div id="ml083.s37"><h4>h. Summary of probe properties</h4><p>Compound is soluble at 10 mM in DMSO. The compound is not fluorescent with
|
|
blue excitation wavelengths (~340 nm). Solubility in buffer has not been
|
|
determined.</p></div></div><div id="ml083.s38"><h3>2. Probe</h3><div id="ml083.s39"><h4>a. Chemical name</h4><p>
|
|
2,4-dimethyl-4H-thieno[3,2-b]pyrrole-2-(2-fluorobenzyl)pyridazin-3(2H)-one
|
|
[<a href="/pcsubstance/?term=ML082[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML082</a>]
|
|
</p></div><div id="ml083.s40"><h4>b. Probe chemical structure</h4><div id="ml083.fu15" class="figure"><div class="graphic"><img src="/books/NBK47338/bin/ml083fu17.jpg" alt="Image ml083fu17" /></div></div></div><div id="ml083.s41"><h4>c. Structural Verification Information of probe SID</h4><p><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.64 (d, 3H,
|
|
<i>J</i>=1.2 Hz), 4.27 (s, 3H), 5.53 (s, 2H), 6.92
|
|
(q, 1H, <i>J</i>=1.2 Hz), 7.02–7.09 (m,
|
|
2H), 7.19–7.26 (m, 2H), 8.20 (s, 1H). HRMS; Calculated for
|
|
C<sub>17</sub>H<sub>15</sub>FN<sub>3</sub>OS+
|
|
(M+H): 328.0920, found: 328.0925.</p></div><div id="ml083.s42"><h4>d. PubChem CID (corresponding to the SID)</h4><p>CID-654376</p></div><div id="ml083.s43"><h4>e. Availability from a vendor</h4><p>Aliquots of MLS-000076148 (CID-654376) are available from the NCGC upon
|
|
request.</p></div><div id="ml083.s44"><h4>f. Mode of action for biological activity of probe</h4><p>The probe is a member of a series of highly specific allosteric activators
|
|
for the tumor-specific isoform of human pyruvate kinase (M2 isoform). The
|
|
activation occurs in a manner that is kinetically similar to the natural
|
|
activator (FBP) by decreasing the Km for PEP and reducing the cooperative
|
|
binding of PEP.</p></div><div id="ml083.s45"><h4>g. Detailed synthetic pathway for making probe</h4><p>See Scheme above.</p></div><div id="ml083.s46"><h4>h. Summary of probe properties</h4><p>Compound is soluble at 10 mM in DMSO. The compound is not fluorescent with
|
|
blue excitation wavelengths (~340 nm). Solubility in buffer has not been
|
|
determined.</p></div></div></div><div id="ml083.bib"><h2 id="_ml083_bib_">Bibliography</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="ml083.r1">Dombrauckas JD, Santarsiero BD, Mesecar AD. Structural basis for tumor pyruvate kinase M2 allosteric
|
|
regulation and catalysis. <span><span class="ref-journal">Biochemistry. </span>2005;<span class="ref-vol">44</span>:9417–29.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15996096" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15996096</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>2.</dt><dd><div class="bk_ref" id="ml083.r2">Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for
|
|
cancer metabolism and tumour growth. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">452</span>:230–3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18337823" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18337823</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>3.</dt><dd><div class="bk_ref" id="ml083.r3">Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC. Pyruvate kinase M2 is a phosphotyrosine-binding
|
|
protein. <span><span class="ref-journal">Nature. </span>2008;<span class="ref-vol">452</span>:181–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18337815" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18337815</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>4.</dt><dd><div class="bk_ref" id="ml083.r4">Warburg O. On the origin of cancer cells. <span><span class="ref-journal">Science. </span>1956;<span class="ref-vol">123</span>:309–14.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/13298683" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 13298683</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>5.</dt><dd><div class="bk_ref" id="ml083.r5">Fan F, Wood KV. Bioluminescent assays for high-throughput
|
|
screening. <span><span class="ref-journal">Assay Drug Dev Technol. </span>2007;<span class="ref-vol">5</span>:127–36.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17355205" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17355205</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>6.</dt><dd><div class="bk_ref" id="ml083.r6">Singh P, Harden BJ, Lillywhite BJ, Broad PM. Identification of kinase inhibitors by an ATP depletion
|
|
method. <span><span class="ref-journal">Assay Drug Dev Technol. </span>2004;<span class="ref-vol">2</span>:161–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15165512" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15165512</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>7.</dt><dd><div class="bk_ref" id="ml083.r7">Inglese J, Auld DS, Jadhav A, Johnson RL, Simeonov A, Yasgar A, Zheng W, Austin CP. Quantitative high-throughput screening: A titration-based
|
|
approach that efficiently identifies biological activities in large
|
|
chemical libraries. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:11473–8.</span> [<a href="/pmc/articles/PMC1518803/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1518803</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16864780" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16864780</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>8.</dt><dd><div class="bk_ref" id="ml083.r8">Auld DS, Zhang YQ, Southall NT, Rai G, Landsman M, Maclure J, Langevin D, Thomas CJ, Austin CP, Inglese J. A Basis for Reduced Chemical Library Inhibition of Firefly
|
|
Luciferase Obtained from Directed Evolution. <span><span class="ref-journal">J Med Chem. </span>2009;<span class="ref-vol">52</span>:1450–1458.</span> [<a href="/pmc/articles/PMC3430137/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3430137</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19215089" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19215089</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>9.</dt><dd><div class="bk_ref" id="ml083.r9">Yasgar A, Shinn P, Jadhav A, Auld DS, Michael S, Zheng W, Austin CP, Inglese J, Simeonov A. Compound Management for Quantitative High-Throughput
|
|
Screening. <span><span class="ref-journal">J Assoc Lab Automation. </span>2008;<span class="ref-vol">13</span>:79–89.</span> [<a href="/pmc/articles/PMC2390859/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC2390859</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18496600" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18496600</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>10.</dt><dd><div class="bk_ref" id="ml083.r10">Hannaert V, Yernaux C, Rigden DJ, Fothergill-Gilmore LA, Opperdoes FR, Michels PA. The putative effector-binding site of Leishmania mexicana
|
|
pyruvate kinase studied by site-directed mutagenesis. <span><span class="ref-journal">FEBS Lett. </span>2002;<span class="ref-vol">514</span>:255–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11943161" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11943161</span></a>]</div></dd></dl></dl></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK47338_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Douglas Auld</span>, <span itemprop="author">Min Shen</span>, <span itemprop="author">Amanda P Skoumbourdis</span>, <span itemprop="author">Jian-kang Jiang</span>, <span itemprop="author">Matthew Boxer</span>, <span itemprop="author">Noel Southall</span>, <span itemprop="author">James Inglese</span>, and <span itemprop="author">Craig Thomas</span>.</p><h4>Affiliations</h4><div class="affiliation"><sup>1</sup> NIH Chemical Genomics Center</div><h3>Publication History</h3><p class="small">Received: <span itemprop="datePublished">April 16, 2009</span>; Last Update: <span itemprop="dateModified">August 6, 2010</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p>National Center for Biotechnology Information (US), Bethesda (MD)</p><h3>NLM Citation</h3><p>Auld D, Shen M, Skoumbourdis AP, et al. Identification of activators for the M2 isoform of human pyruvate kinase. 2009 Apr 16 [Updated 2010 Aug 6]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. <span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/mlprobe/ml084/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/mlprobe/ml081/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobml083tu1"><div id="ml083.tu1" class="table"><h3><span class="title">Probe 1 Structure & Characteristics</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.tu1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.tu1_lrgtbl__"><table class="no_top_margin"><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PubChem CID</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CID-650361</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SID</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a></td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Internal ID</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">NCGC-00030335</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Molecular Weight</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">454.52</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Molecular Formula</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">C<sub>19</sub>H<sub>22</sub>N<sub>2</sub>O<sub>7</sub>S<sub>2</sub></td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">XLogP</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H-Bond Donor</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H-Bond Acceptor</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">9</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rotatable Bond Count</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Exact Mass</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">454.086842</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Topological Polar Surface Area</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">103</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Heavy Atom Count</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">30</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml083fu1"><div id="ml083.fu1" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu1.jpg" alt="Image ml083fu1" /></div></div></article><article data-type="table-wrap" id="figobml083tu2"><div id="ml083.tu2" class="table"><h3><span class="title">PubChem Primary Bioassay Identifier (AID): 1631</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.tu2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.tu2_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml083.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CID/ML</th><th id="hd_h_ml083.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Target Name</th><th id="hd_h_ml083.tu2_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">IC50/EC 50 (nM) [SID,
|
|
AID]</th><th id="hd_h_ml083.tu2_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Anti-target Name(s)</th><th id="hd_h_ml083.tu2_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">IC50/EC50 (μM) [SID,
|
|
AID]</th><th id="hd_h_ml083.tu2_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Selectivity</th><th id="hd_h_ml083.tu2_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Secondary Assay(s) Name: IC50/EC50 (nM)
|
|
[SID, AID]</th></tr></thead><tbody><tr><td headers="hd_h_ml083.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">650361/<a href="/pcsubstance/?term=ML083[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML083</a></td><td headers="hd_h_ml083.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-M2</td><td headers="hd_h_ml083.tu2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0.6 ± 0.3 [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1540" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1540</a>]</td><td headers="hd_h_ml083.tu2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-R</td><td headers="hd_h_ml083.tu2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">30%@ 57 μM
|
|
[<a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a>, <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1543" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1543</a>]</td><td headers="hd_h_ml083.tu2_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">≥ 30-fold</td><td headers="hd_h_ml083.tu2_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PK-LDH, [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1543" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1543</a>]</td></tr><tr><td headers="hd_h_ml083.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-L</td><td headers="hd_h_ml083.tu2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Inactive[<a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1541" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1541</a>]</td><td headers="hd_h_ml083.tu2_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">≥ 100-fold</td><td headers="hd_h_ml083.tu2_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PK-LDH, [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1541" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1541</a>]</td></tr><tr><td headers="hd_h_ml083.tu2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-M1</td><td headers="hd_h_ml083.tu2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Inactive[<a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1542" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1542</a>]</td><td headers="hd_h_ml083.tu2_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">≥ 100-fold</td><td headers="hd_h_ml083.tu2_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PK-LDH, [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/847943" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-847943</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1542" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1542</a>]</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobml083tu3"><div id="ml083.tu3" class="table"><h3><span class="title">Probe 2 Structure & Characteristics</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.tu3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.tu3_lrgtbl__"><table class="no_top_margin"><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PubChem CID</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CID-654376</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SID</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a></td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Internal ID</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">NCGC-00031955</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Molecular Weight</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">327.38</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Molecular Formula</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">C17H14FN3OS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">XLogP</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">3.1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H-Bond Donor</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H-Bond Acceptor</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rotatable Bond Count</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Exact Mass</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">327.08</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Topological Polar Surface Area</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">37.6</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Heavy Atom Count</td><td rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">23</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml083fu2"><div id="ml083.fu2" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu2.jpg" alt="Image ml083fu2" /></div></div></article><article data-type="table-wrap" id="figobml083tu4"><div id="ml083.tu4" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.tu4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.tu4_lrgtbl__"><table><thead><tr><th id="hd_h_ml083.tu4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CID/ML</th><th id="hd_h_ml083.tu4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Target Name</th><th id="hd_h_ml083.tu4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">IC50/EC 50 (nM) [SID,
|
|
AID]</th><th id="hd_h_ml083.tu4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Anti-target Name(s)</th><th id="hd_h_ml083.tu4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">IC50/EC50 (μM) [SID,
|
|
AID]</th><th id="hd_h_ml083.tu4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Selectivity</th><th id="hd_h_ml083.tu4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Secondary Assay(s) Name: IC50/EC50 (nM)
|
|
[SID, AID]</th></tr></thead><tbody><tr><td headers="hd_h_ml083.tu4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CID-654376/<a href="/pcsubstance/?term=ML082[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML082</a></td><td headers="hd_h_ml083.tu4_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-M2</td><td headers="hd_h_ml083.tu4_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0.2 ± 0.1 [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1540" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1540</a>]</td><td headers="hd_h_ml083.tu4_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-L</td><td headers="hd_h_ml083.tu4_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">4 [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1541" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1541</a>]</td><td headers="hd_h_ml083.tu4_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">>10 fold</td><td headers="hd_h_ml083.tu4_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PK-LDH, [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1541" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1541</a>]</td></tr><tr><td headers="hd_h_ml083.tu4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu4_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu4_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu4_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-R</td><td headers="hd_h_ml083.tu4_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">4 [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1543" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1543</a>]</td><td headers="hd_h_ml083.tu4_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">>10 fold</td><td headers="hd_h_ml083.tu4_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PK-LDH, [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1543" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1543</a>]</td></tr><tr><td headers="hd_h_ml083.tu4_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu4_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu4_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_ml083.tu4_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPK-M1</td><td headers="hd_h_ml083.tu4_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Inactive [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1542" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1542</a>]</td><td headers="hd_h_ml083.tu4_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">>100 fold</td><td headers="hd_h_ml083.tu4_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PK-LDH, [<a href="https://pubchem.ncbi.nlm.nih.gov/substance/851783" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-851783</a>,
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1542" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1542</a>]</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml083fu3"><div id="ml083.fu3" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu3.jpg" alt="A) Shown is normal respiration occurring in non-cancerous cell-types" /></div><div class="caption"><p><b>A)</b> Shown is normal respiration occurring in non-cancerous
|
|
cell-types. PK-M1 is constitutively active and acts primarily to drive
|
|
ATP formation. <b>B)</b> Shown is altered metabolism that occurs
|
|
in cancer cells. In this case, the activity of the PK-M2 isoform is
|
|
activated by phosphorylated sugars (e.g. FBP) and inhibited by
|
|
tyrosine-phosphorylated proteins derived from growth factor signaling.
|
|
The decrease in activity of PK-M2 in response to growth signals is
|
|
predicted to build-up intermediates of glycolysis and feed proliferation
|
|
of the cancer cells.</p></div></div></article><article data-type="table-wrap" id="figobml083tu5"><div id="ml083.tu5" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.tu5/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.tu5_lrgtbl__"><table><thead><tr><th id="hd_h_ml083.tu5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">AID</th><th id="hd_h_ml083.tu5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Target</th><th id="hd_h_ml083.tu5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Concentration</th><th id="hd_h_ml083.tu5_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Bioassay type</th></tr></thead><tbody><tr><td headers="hd_h_ml083.tu5_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1631" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1631</a></td><td headers="hd_h_ml083.tu5_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPKM2 Activator</td><td headers="hd_h_ml083.tu5_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">57 μM to 0.4 nM</td><td headers="hd_h_ml083.tu5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Primary qHTS</td></tr><tr><td headers="hd_h_ml083.tu5_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1634" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1634</a></td><td headers="hd_h_ml083.tu5_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPKM2 Inhibitor</td><td headers="hd_h_ml083.tu5_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">57 μM to 0.4 nM</td><td headers="hd_h_ml083.tu5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Primary qHTS</td></tr><tr><td headers="hd_h_ml083.tu5_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1540" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1540</a></td><td headers="hd_h_ml083.tu5_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPKM2</td><td headers="hd_h_ml083.tu5_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">57 μM to 0.4 nM</td><td headers="hd_h_ml083.tu5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Confirmatory</td></tr><tr><td headers="hd_h_ml083.tu5_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1541" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1541</a></td><td headers="hd_h_ml083.tu5_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPKL</td><td headers="hd_h_ml083.tu5_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">57 μM to 0.4 nM</td><td headers="hd_h_ml083.tu5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Selectivity</td></tr><tr><td headers="hd_h_ml083.tu5_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1542" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1542</a></td><td headers="hd_h_ml083.tu5_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPKM1</td><td headers="hd_h_ml083.tu5_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">57 μM to 0.4 nM</td><td headers="hd_h_ml083.tu5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Selectivity</td></tr><tr><td headers="hd_h_ml083.tu5_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1543" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1543</a></td><td headers="hd_h_ml083.tu5_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">hPKR</td><td headers="hd_h_ml083.tu5_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">57 μM to 0.4 nM</td><td headers="hd_h_ml083.tu5_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Selectivity</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml083f1"><div id="ml083.f1" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f1.jpg" alt="Figure 2. Pyruvate kinase-luciferase coupled assay." /></div><h3><span class="label">Figure 2</span><span class="title">Pyruvate kinase-luciferase coupled assay</span></h3></div></article><article data-type="table-wrap" id="figobml083t1"><div id="ml083.t1" class="table"><h3><span class="label">Table 1</span><span class="title">Final 1536-well assay protocol</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.t1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.t1_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Step</th><th id="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">Parameter</th><th id="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">Value</th><th id="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">Description</th></tr></thead><tbody><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1</td><td headers="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Reagent</td><td headers="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3 μL</td><td headers="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEP/hPK-M2 buffer (0.5 mM and 0.1
|
|
nM final, respectively)</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">2</td><td headers="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Controls</td><td headers="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">23 nl</td><td headers="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Activator control
|
|
(NCGC00031955)</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3</td><td headers="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Library compounds</td><td headers="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">23 nl</td><td headers="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">57 μM to 0.4 nM
|
|
dilution series</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">4</td><td headers="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Reagent</td><td headers="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1 μL</td><td headers="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADP buffer (0.1 mM final)</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">5</td><td headers="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incubation time</td><td headers="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">1 hr</td><td headers="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Room temperature</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">6</td><td headers="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Reagent</td><td headers="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">2 μL</td><td headers="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Kinase-Glo</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">7</td><td headers="hd_h_ml083.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Assay readout</td><td headers="hd_h_ml083.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">luminescence</td><td headers="hd_h_ml083.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ViewLux</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1 hd_h_ml083.t1_1_1_1_2 hd_h_ml083.t1_1_1_1_3 hd_h_ml083.t1_1_1_1_4" colspan="4" rowspan="1" style="vertical-align:top;"><b>Step Notes</b></td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">1</td><td headers="hd_h_ml083.t1_1_1_1_2 hd_h_ml083.t1_1_1_1_3 hd_h_ml083.t1_1_1_1_4" colspan="3" rowspan="1" style="vertical-align:top;">Black walled clear bottom Greiner white solid plates; 4 tips
|
|
dispense to all wells except column 3 of buffer 0.133 nM hPK-M2,
|
|
0.67 mM PEP, 50 mM Imidazole pH 7.2, 50 mM KCl, 7 mM MgCl2,
|
|
0.01% Tween, 0.05% BSA. Column 3, 1 tip of
|
|
same buffer without hPK-M2.</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">2</td><td headers="hd_h_ml083.t1_1_1_1_2 hd_h_ml083.t1_1_1_1_3 hd_h_ml083.t1_1_1_1_4" colspan="3" rowspan="1" style="vertical-align:top;">Column 1, NCGC00031955 Activator titration 57 μM start,
|
|
16 points in duplicate 1:2 dilutions; Column 2 neutral, DMSO only;
|
|
Column 3 no enzyme; Column 4, top 16 rows are NCGC0031955 at 57
|
|
μM, bottom 16 rows are DMSO only.</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">3</td><td headers="hd_h_ml083.t1_1_1_1_2 hd_h_ml083.t1_1_1_1_3 hd_h_ml083.t1_1_1_1_4" colspan="3" rowspan="1" style="vertical-align:top;">Pintool transfer (tip wash sequence; DMSO, iPA, MeOH, 3-s vacuum
|
|
dry)</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">4</td><td headers="hd_h_ml083.t1_1_1_1_2 hd_h_ml083.t1_1_1_1_3 hd_h_ml083.t1_1_1_1_4" colspan="3" rowspan="1" style="vertical-align:top;">ADP in same 4 tips dispense to all wells of buffer containing 0.4
|
|
mM ADP (final assay 0.1 mM), 50 mM Imidazole pH 7.2, 50 mM KCl, 7 mM
|
|
MgCl2, 0.01% Tween, 0.05% BSA.</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">5</td><td headers="hd_h_ml083.t1_1_1_1_2 hd_h_ml083.t1_1_1_1_3 hd_h_ml083.t1_1_1_1_4" colspan="3" rowspan="1" style="vertical-align:top;">Plates covered with stainless steel rubber gasket-lined lids
|
|
containing pin holes for gas exchange</td></tr><tr><td headers="hd_h_ml083.t1_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">6</td><td headers="hd_h_ml083.t1_1_1_1_2 hd_h_ml083.t1_1_1_1_3 hd_h_ml083.t1_1_1_1_4" colspan="3" rowspan="1" style="vertical-align:top;">Kinase-Glo detection. Luciferase-based detection of ATP product</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml083f2"><div id="ml083.f2" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f2.jpg" alt="Figure 2. qHTS Performance Summary." /></div><h3><span class="label">Figure 2</span><span class="title">qHTS Performance Summary</span></h3></div></article><article data-type="fig" id="figobml083f3"><div id="ml083.f3" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f3.jpg" alt="Scheme 1. Example qHTS data and classification scheme for assignment of resulting curve-fit data into classes." /></div><h3><span class="label">Scheme 1</span><span class="title">Example qHTS data and classification scheme for assignment of
|
|
resulting curve-fit data into classes</span></h3><div class="caption"><p><b>Top</b>, qHTS curve-fit data from <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/361" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-361</a> binned into
|
|
curve classifications 1–4 based classification
|
|
criteria. <b>Below</b>, Examples of curves fitting the
|
|
following classification criteria: Class 1 curves display two
|
|
asymptotes, an inflection point, and r2 ≥ 0.9;
|
|
subclasses 1a (blue) vs. 1b (orange) are differentiated by full
|
|
(>80%) vs. partial (≤
|
|
80%) response. Class 2 curves display a single
|
|
left-hand asymptote and inflection point; subclasses 2a (blue)
|
|
and 2b (orange) are differentiated by a max response and r2,
|
|
>80% and >0.9 or
|
|
<80% and <0.9, respectively. Class 3
|
|
curves have a single left-hand asymptote, no inflection point,
|
|
and a response >3SD the mean activity of the sample
|
|
field. Class 4 defines those samples showing no activity across
|
|
the concentration range. Specifically, for the identification of
|
|
the Probe series 1, the filtering shown in <a class="figpopup" href="/books/NBK47338/figure/ml083.f4/?report=objectonly" target="object" rid-figpopup="figml083f4" rid-ob="figobml083f4">Figure 3</a> below was used.</p></div></div></article><article data-type="fig" id="figobml083f4"><div id="ml083.f4" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f4.jpg" alt="Figure 3. Summary of activity from the qHTS." /></div><h3><span class="label">Figure 3</span><span class="title">Summary of activity from the qHTS</span></h3><div class="caption"><p>The table summarizes the number actives associated with CRC
|
|
classes described in <a class="figpopup" href="/books/NBK47338/figure/ml083.f1/?report=objectonly" target="object" rid-figpopup="figml083f1" rid-ob="figobml083f1">Scheme
|
|
1</a>(highlighted in red are the percentages for the high
|
|
quality activating CRCs. The flow chart below summarizes the how
|
|
this information was used to subsequently used to define
|
|
SAR.</p></div></div></article><article data-type="fig" id="figobml083fu4"><div id="ml083.fu4" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu4.jpg" alt="Mode of action." /></div><h3><span class="title">Mode of action</span></h3><div class="caption"><p>Both CID-650361 (<b>A</b>) and CID-654376 (<b>B</b>) affect
|
|
the cooperativity of PEP binding with little affect on ADP binding in a
|
|
manner similar to FBP but with lower efficacy. Kinetics of substrate
|
|
binding in the presence (open circles) or absence (filled squares) of
|
|
activator (10 μM was used). Vo, initial rate in pmol/min as
|
|
determined in the PK-LDH coupled assay</p></div></div></article><article data-type="fig" id="figobml083f5"><div id="ml083.f5" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f5.jpg" alt="Scheme 1" /></div><h3><span class="label">Scheme 1</span></h3></div></article><article data-type="fig" id="figobml083f6"><div id="ml083.f6" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f6.jpg" alt="Scheme 2" /></div><h3><span class="label">Scheme 2</span></h3></div></article><article data-type="fig" id="figobml083f7"><div id="ml083.f7" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f7.jpg" alt="Scheme 3" /></div><h3><span class="label">Scheme 3</span></h3></div></article><article data-type="fig" id="figobml083f8"><div id="ml083.f8" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f8.jpg" alt="Scheme 4" /></div><h3><span class="label">Scheme 4</span></h3></div></article><article data-type="table-wrap" id="figobml083tu6"><div id="ml083.tu6" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.tu6/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.tu6_lrgtbl__"><table><thead><tr><th id="hd_h_ml083.tu6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"></th><th id="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>1</sub></th><th id="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>2</sub></th><th id="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>3</sub></th><th id="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>4</sub></th><th id="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>5</sub></th><th id="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">
|
|
<i>IC</i>
|
|
<i>
|
|
<sub>50</sub>
|
|
</i>
|
|
<i>(μM)</i>
|
|
</th><th id="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">
|
|
<i>Max Responce</i>
|
|
</th></tr></thead><tbody><tr><td headers="hd_h_ml083.tu6_1_1_1_1" rowspan="17" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<div class="graphic"><img src="/books/NBK47338/bin/ml083fu5.jpg" alt="Image ml083fu5.jpg" /></div>
|
|
</td><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.398</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">310</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OMe</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.562</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">195</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.708</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">162</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OCF3</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.00</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">21</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.708</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">369</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Br</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4.47</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">310</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">COOH</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">15.8</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">164</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CH<sub>2</sub>COOH</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">17.8</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">276</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"><i>n</i>Pr</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">31.6</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">234</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">COOMe</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.224</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">306</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">COOH</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.355</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">12.5</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OMe</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.447</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">103</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OH</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.562</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">227</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OMe</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.00</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">232</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.21</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">199</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CF<sub>3</sub></td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.26</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">193</td></tr><tr><td headers="hd_h_ml083.tu6_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu6_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu6_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.58</td><td headers="hd_h_ml083.tu6_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">229</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml083f9"><div id="ml083.f9" class="figure bk_fig"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083f9.jpg" alt="Scheme 5" /></div><h3><span class="label">Scheme 5</span></h3></div></article><article data-type="fig" id="figobml083fu5"><div id="ml083.fu5" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu6.jpg" alt="Image ml083fu6" /></div></div></article><article data-type="fig" id="figobml083fu6"><div id="ml083.fu6" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu7.jpg" alt="Image ml083fu7" /></div></div></article><article data-type="fig" id="figobml083fu7"><div id="ml083.fu7" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu8.jpg" alt="Image ml083fu8" /></div></div></article><article data-type="fig" id="figobml083fu8"><div id="ml083.fu8" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu9.jpg" alt="Image ml083fu9" /></div></div></article><article data-type="fig" id="figobml083fu9"><div id="ml083.fu9" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu10.jpg" alt="Image ml083fu10" /></div></div></article><article data-type="fig" id="figobml083fu10"><div id="ml083.fu10" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu11.jpg" alt="Image ml083fu11" /></div></div></article><article data-type="fig" id="figobml083fu11"><div id="ml083.fu11" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu12.jpg" alt="Image ml083fu12" /></div></div></article><article data-type="fig" id="figobml083fu12"><div id="ml083.fu12" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu13.jpg" alt="Image ml083fu13" /></div></div></article><article data-type="fig" id="figobml083fu13"><div id="ml083.fu13" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu14.jpg" alt="Image ml083fu14" /></div></div></article><article data-type="table-wrap" id="figobml083tu7"><div id="ml083.tu7" class="table"><h3><span class="title">SAR of CID-654376 analogs</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK47338/table/ml083.tu7/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml083.tu7_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml083.tu7_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;"></th><th id="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>1</sub></th><th id="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>2</sub></th><th id="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>3</sub></th><th id="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>4</sub></th><th id="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">R<sub>5</sub></th><th id="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">
|
|
<i>IC</i>
|
|
<i>
|
|
<sub>50</sub>
|
|
</i>
|
|
<i>( μM)</i>
|
|
</th><th id="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">
|
|
<i>Max Responce</i>
|
|
</th></tr></thead><tbody><tr><td headers="hd_h_ml083.tu7_1_1_1_1" rowspan="45" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<div class="graphic"><img src="/books/NBK47338/bin/ml083fu15.jpg" alt="Image ml083fu15.jpg" /></div>
|
|
</td><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.200</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">354</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.251</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">330</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.282</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">331</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OMe</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.282</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">353</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.316</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">302</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.316</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">389</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CF<sub>3</sub></td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.316</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">316</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.355</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">365</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.398</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">322</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.398</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">389</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.447</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">313</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OMe</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.501</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">409</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.501</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">322</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.562</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">293</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.562</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">335</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.631</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">324</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.631</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">382</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Br</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.631</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">384</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.631</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">326</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Br</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.708</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">318</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.708</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">308</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.708</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">309</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.708</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">332</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.708</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">323</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.794</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">355</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.794</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">348</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.794</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">303</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.794</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">285</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.891</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">309</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.891</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">351</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.891</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">62</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.00</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">380</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.00</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">321</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.12</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">323</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.12</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">343</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">OMe</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.41</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">297</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.41</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">307</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.59</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">237</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.59</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">272</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Br</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.59</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">250</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CF<sub>3</sub></td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.78</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">292</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.78</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">335</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Me</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2.00</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">381</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Cl</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2.00</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">347</td></tr><tr><td headers="hd_h_ml083.tu7_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">F</td><td headers="hd_h_ml083.tu7_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">H</td><td headers="hd_h_ml083.tu7_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2.00</td><td headers="hd_h_ml083.tu7_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">266</td></tr></tbody></table></div></div></article><article data-type="fig" id="figobml083fu14"><div id="ml083.fu14" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu16.jpg" alt="Image ml083fu16" /></div></div></article><article data-type="fig" id="figobml083fu15"><div id="ml083.fu15" class="figure"><div class="graphic"><img data-src="/books/NBK47338/bin/ml083fu17.jpg" alt="Image ml083fu17" /></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal106 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|